Sarcopenia in Chronic Lung Diseases

Asthma Clinical Trial

Official title:

Epidemiological Study of Sarcopenia in Patients With Chronic Lung Diseases: A Prospective Registry Cohort Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06280443
• Other study ID #: CE22407B
• Status: Recruiting
• Start date: November 25, 2022
• Est. completion date: September 30, 2032

Study information

• Verified date: April 2024
• Source: Taichung Veterans General Hospital
• Contact: Pin-Kuei Fu
• Phone: 04-23592525
• Email: fpk113[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Inclusion criteria A)Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.

B) Patients who agree to provide the ID card number to the research team for usage as a link to the National Health Insurance research database and Health bank to explore the continuity of care and the use of medical resources

Description:

This study is a prospective, multi-center, and non-invasive cohort study. All participants are diagnosed with Asthma, COPD and ILD. We use SARC-Calf questionnaire, Frailty questionnaire and Grip strength as a tool for prescreen. According to the 2019 Asian Sarcopenia Consensus, participants are examined by SARC-Calf questionnaire, grip strength test and a physical performance test, including sit-stand test, short physical performance battery (SPPB), gait speed test and six-minute walk test. Bioelectrical impedance analysis (BIA) and Dual-energy X-ray absorptiometry (DXA) are applied to all participants by to analyze body composition. Participants are further classified into no Sarcopenia group, Sarcopenia group, and severe Sarcopenia group to derive the prevalence.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 300
• Est. completion date: September 30, 2032
• Est. primary completion date: October 13, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

1. Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.

2. Those who meet the conditions for frailty diagnosis after assessment by the Frailty Scale

3. Patients who agree to provide the ID card number to the research team for usage as a link to the National Health Insurance research database and Health bank to explore the continuity of care and the use of medical resources

4. Age>=20

Exclusion Criteria:

1. Patients who refuse to sign the consent form

2. Patients who are bed ridden or unable to walk due to physical disabilities

3. Patients with terminal cancer or human acquired immunodeficiency syndrome

4. Patients with edema (pitting edema +2)

Related Conditions & MeSH terms

• Asthma
• COPD
• ILD
• Lung Diseases
• Sarcopenia

Locations

Country	Name	City	State
Taiwan	Taichung Veterans General Hospital	Taichung

Sponsors (1)

Lead Sponsor	Collaborator
Taichung Veterans General Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	sarcopenia rate	The proportion of sarcopenia diagnosis in patients with chronic lung diseases	1 year